Lead set for nerve stimulator and method of operation thereof
View Patent ↗Single-use electrical leads for a nerve stimulator are disclosed. The leads include a status flag element such as a fuse, which is deliberately blown after use of the leads has begun to indicate that the leads are not to be reused. The nerve stimulator has a “test mode” that determines a current value for treatment, and a “therapy mode” that administers treatment with the chosen current value. If the fuse in the electrical leads is blown (not conducting), then the stimulator assumes that the leads have already been used and does not enter therapy mode, and optionally may not enter test mode. If the fuse in the electrical leads is intact (conducting), or not blown, then the stimulator assumes that the leads are as yet unused, and allows the user to enter either test mode or therapy mode. The fuse is deliberately blown after a particular amount of time spent in therapy mode. After the fuse is blown, the user may still complete the therapy mode, even though the fuse is non-conducting, although the user may not initiate another therapy mode (and optionally may not initiate another test mode) using the blown leads. Preferably the fuse is electrically isolated from the leads that contact the patient.
1. A lead set for a nerve stimulator having a one-way fit connection site, comprising:
a one-way fit plastic connector configured to mate with the one-way fit connection site;
a transcutaneous electrode;
a first lead extending from the connector and terminating in the transcutaneous electrode;
an attachment member for removably receiving a percutaneous needle electrode;
a second lead extending from the connector and terminating in the attachment member;
a fuse disposed entirely in the connector, said fuse including a functional status that is changeable during delivery of therapy after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of said therapy;
a third lead disposed entirely in the connector and connected to the fuse; and
a fourth lead disposed entirely in the connector and connected to the fuse;
wherein the first lead and the second lead are electrically isolated from one another and physically separated at the transcutaneous electrode and the attachment member; and
wherein the fuse and the third and fourth leads are electrically isolated from both the first lead and the second lead; and
wherein the non-operational condition of the fuse is configured to prevent re-use of the lead set after delivery of the initial therapy.
2. A nerve stimulation kit for a nerve stimulator having a one-way fit connection site, comprising:
a percutaneous needle electrode; a
packaged alcohol pad; and
a lead set comprising:
a one-way fit plastic connector configured to mate with the one-way fit connection site;
a transcutaneous electrode;
a first lead extending from the connector and terminating in the transcutaneous electrode;
a needle clip for removably receiving the percutaneous needle electrode;
a second lead extending from the connector and terminating in the needle clip;
a fuse disposed entirely in the connector, said fuse including a functional status that is changeable during delivery of therapy after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of therapy and is configured to prevent re-use of the lead set after delivery of the therapy;
a third lead disposed entirely in the connector and connected to the fuse; and
a fourth lead disposed entirely in the connector and connected to the fuse;
wherein the first lead and the second lead are electrically isolated from one another and physically separated at the transcutaneous electrode and the needle clip; and
wherein the fuse and the third and fourth leads are electrically isolated from both the first lead and the second lead.
3. A lead set comprising:
a first electrically conductive lead wire having a first end thereof and a transcutaneous electrode at a second end thereof;
a second electrically conductive lead wire having a first end thereof and an electrically conductive attachment member at a second end thereof, the attachment member being suspendable from a percutaneous needle electrode when inserted in a patient;
a single-use mechanism comprising a fuse, said fuse including a functional status that is changeable during delivery of therapy to a patient after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of therapy and is adapted to discourage or make difficult re-use of the lead set for electro-nerve stimulation after said delivery of the therapy;
a connector, the first end of the first electrically conductive lead wire and the first end of the second electrically conductive lead wire being disposed in the connector.
4. A lead set for a nerve stimulator, comprising:
a keyed connector block having first, second, third and fourth conductors;
a first lead extending from the first conductor of the connector block and terminating in a patch electrode having adhesive on a surface thereof;
a second lead extending from the second conductor of the connector block and terminating in a needle clip; and
a fuse disposed in the connector block, the fuse being connected between the third and fourth conductors, said fuse including a functional status that is changeable during delivery of therapy after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of therapy and is configured to prevent re-use of the lead set after delivery of the initial therapy.
5. The lead set of claim 4 , wherein:
the patch electrode is permanently connected to the first lead; the needle clip is permanently connected to the second lead;
the first and second leads are merged in proximity to the connector block, and are separated away from the connector block; and
the connector block is plastic.
6. The lead set of claim 4 , wherein the first lead is electrically isolated from the second lead and the fuse.
7. The lead set of claim 4 , wherein the second lead is electrically isolated from the first lead and the fuse.
8. The lead set of claim 4 , wherein:
the first lead is electrically isolated from the second lead and the fuse; and
the second lead is electrically isolated from the first lead and the fuse.
9. The lead set of claim 4 , wherein the connector block is keyed to a connection site of a controller unit.
10. A lead set for a nerve stimulator, comprising:
a keyed connector block;
a first lead extending from a first port disposed in the connector block and terminating in a patch electrode;
a second lead extending from a second port disposed in the connector block and terminating in a needle clip; and
a fuse disposed in the connector block and electrically isolated from both the first lead and the second lead, the fuse being coupled between a third port and a fourth port disposed in the connector block, said fuse including a functional status that is changeable during delivery of therapy after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of therapy and is configured to prevent re-use of the lead set after delivery of the therapy.
11. A lead set for a nerve stimulator, comprising:
a keyed connector block having first, second, third and fourth conductors;
a first lead extending from the first conductor of the connector block and terminating in a patch electrode having adhesive on a surface thereof;
a second lead extending from the second conductor of the connector block and terminating in a needle; and
a fuse disposed in the connector block, the fuse being connected between the third and fourth conductors, said fuse including a functional status that is changeable during delivery of therapy after a pre-determined time period from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of therapy and is configured to prevent re-use of the lead set after delivery of the initial therapy.
12. The lead set of claim 11 , wherein the first lead is electrically isolated from the second lead and the fuse.
13. The lead set of claim 11 , wherein the second lead is electrically isolated from the first lead and the fuse.
14. The lead set of claim 11 , wherein:
the first lead is electrically isolated from the second lead and the fuse; and
the second lead is electrically isolated from the first lead and the fuse.